Guidelines for Clinical Trials of Frontal Fibrosing Alopecia: Consensus Recommendations from the International FFA Cooperative Group

    Elise A. Olsen, Matthew Harries, Antonella Tosti, Wilma F. Bergfeld, Ulrike Blume-Peytavi, Valerie D. Callender, Vasiliki Chasapi, Osvaldo Correia, George Cotsarelis, Rachita Dhurat, Ncoza C. Dlova, Isabella Doche, Nkechi Anne Enechukwu, Ramón Grimalt, Satoshi Itami, Maria Hordinsky, Kuzma Кhobzei, W. S. Lee, Subrata Malakar, Andrew G. Messenger, Amy J. McMichael, Paradi Mirmirani, Yuliya Ovcharenko, Sofia Papanikou, Giselle Martins Pinto, Bianca Maria Piraccini, Rodrigo Pirmez, P. Reygagne, Janet L. Roberts, Lidia Rudnicka, David Saceda‐Corralo, Jerry Shapiro, Tatiana Silyuk, Rodney Sinclair, Rui Oliveira Soares, A. Souissi, Annika Vogt, Ken Washenik, Abraham Zlotogorski, Douglas Canfield, Sergio Vañó‐Galván
    Image of study
    TLDR Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.
    The document outlines consensus recommendations from the International FFA Cooperative Group (IFFACG) for clinical trials on Frontal Fibrosing Alopecia (FFA), aiming to standardize diagnostic criteria, severity rating, staging, and assessment methods. The IFFACG, comprising hair loss experts, achieved over 90% agreement on these guidelines to ensure consistent and meaningful data collection on FFA worldwide. This will enhance clinical and basic research on well-defined patient populations and facilitate the evaluation of treatment efficacy and safety. The guidelines introduce a Global Staging Score and the ALODEXFFA Score for simplified assessment of hair density and extent, which are expected to improve data aggregation and support further research to fill existing knowledge gaps about FFA.
    Discuss this study in the Community →

    Research cited in this study

    39 / 39 results

    Related Community Posts Join

    6 / 663 results
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community 9 months on Fin - no progress , should I get on Dutasteride?

      in Chat  10 upvotes 1 year ago
      The user has been using finasteride, minoxidil, and nizoral for hair loss but hasn't seen regrowth, only maintenance. They are considering switching to dutasteride, which is believed to be more effective, but are concerned about potential side effects.

      community Hairloss all over body and head

      in Treatment  2 upvotes 1 month ago
      A 25-year-old experiencing hair thinning all over the body and head, despite using minoxidil and having low vitamin D levels, is advised to seek a second opinion from a dermatologist specializing in hair loss. The likely diagnosis is diffuse alopecia areata, which may require treatment with a JAK inhibitor.

      community can someone help me identify these pls

      in Treatment 3 months ago
      The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

    Related Research

    4 / 4 results